-
Innovation Ranking
NewInnovation Ranking – Twist Bioscience Corp
Twist Bioscience Corp (Twist Bioscience) is a synthetic biology company that carries out the development of synthetic DNA and synthetic DNA-based products. The company offers synthetic genes and gene fragments, oligonucleotide, IgG proteins, next-generation sequencing (NGS) tools, drug and target discovery solutions, and synthetic viral controls, infectious disease research tools. Its products are used to treat influenzas, rhinoviruses, respiratory syncytial virus, SARS, MERS and coronaviruses, among others. Twist Bioscience’s silicon-based DNA synthesis platform enables the sequencing process and the production...
-
Company Insights
Innovation and Patenting activity of Twist Bioscience Corp Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Twist Bioscience Corp Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
Trauma Fixation Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Trauma Fixation Pipeline Market Report Overview Trauma Fixation devices are used for the treatment of fractures. These devices provide support for aligning, stabilizing, and immobilizing fractured bones. The Trauma Fixation pipeline market research report provides comprehensive information about the Trauma Fixation pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Segments ·       Internal Fixators ·       Cannulated Screws ·       Plates ·       IM Nails ·       Foot...
-
Company Profile
Twist Bioscience Corp – Company Profile
Twist Bioscience Corp (Twist Bioscience) is a synthetic biology company that carries out the development of synthetic DNA and synthetic DNA-based products. The company offers synthetic genes and gene fragments, oligonucleotide, IgG proteins, next-generation sequencing (NGS) tools, drug and target discovery solutions, and synthetic viral controls, infectious disease research tools. Its products are used to treat influenzas, rhinoviruses, respiratory syncytial virus, SARS, MERS and coronaviruses, among others. Twist Bioscience’s silicon-based DNA synthesis platform enables the sequencing process and the production...
Add to Basket -
Product Insights
Colon Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Colon Cancer Pipeline Drugs Market Overview Colon cancer is cancer that starts in the large intestine (colon). There is no single cause of colon cancer. Nearly all colon cancers begin as noncancerous (benign) polyps, which slowly develop into cancer. Many cases of colon cancer have no symptoms. The following symptoms may indicate colon cancer abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, or other change in bowel habits, narrow stools, and weight loss with...
-
Product Insights
Fragile X Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Fragile X syndrome is caused by a change in a gene called FMR1. It occurs both in males and females. The symptoms of Fragile X Syndrome include delay in crawling, walking, or twisting, hyperactive or impulsive behavior, speech or language delay, and intellectual disability. The Fragile X Syndrome pipeline market research report provides comprehensive information on the therapeutics under development for Fragile X Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration...